{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:28:20Z","timestamp":1791221300666,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1992,2,1]],"date-time":"1992-02-01T00:00:00Z","timestamp":696902400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[1992,2]]},"DOI":"10.1007\/bf00402544","type":"journal-article","created":{"date-parts":[[2004,10,21]],"date-time":"2004-10-21T08:24:45Z","timestamp":1098347085000},"page":"129-138","source":"Crossref","is-referenced-by-count":17,"title":["The effects of different plasma insulin concentrations on lipolytic and ketogenic responses to epinephrine in normal and Type 1 (insulin-dependent) diabetic humans"],"prefix":"10.1007","volume":"35","author":[{"given":"A.","family":"Avogaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Valerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Gnudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Maran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Miola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Duner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Marescotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Iori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Tiengo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Nosadini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/0026-0495(90)90146-4","volume":"39","author":"A Avogaro","year":"1990","unstructured":"Avogaro A, Nosadini R, Doria A et al. (1990) Substrate availability other than glucose in the brain during euglycemia and insulin induced hypoglycemia in dogs. Metabolism 39: 46?50","journal-title":"Metabolism"},{"key":"CR2","first-page":"E606","volume":"258","author":"A Avogaro","year":"1990","unstructured":"Avogaro A, Nosadini R, Doria A et al. (1990) Myocardial metabolism in insulin-deficient diabetic humans without coronary artery disease. Am J Physiol 258: E606-E618","journal-title":"Am J Physiol"},{"key":"CR3","first-page":"R611","volume":"248","author":"R Nosadini","year":"1985","unstructured":"Nosadini R, Avogaro A, Trevisan R et al. (1985) Acetoacetate and 3-hydroxybutyrate kinetics in obese and insulin dependent diabetic humans. Am J Physiol 248: R611-R620","journal-title":"Am J Physiol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1152\/physrev.1983.63.4.1481","volume":"63","author":"WH Pardridge","year":"1983","unstructured":"Pardridge WH (1983) Brain metabolism from the blood brain barrier. Physiol Rev 63: 1481?1535","journal-title":"Physiol Rev"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.bi.49.070180.002143","volume":"49","author":"JD McGarry","year":"1980","unstructured":"McGarry JD, Foster DW (1980) Regulation of hepatic fatty acid oxidation and ketone body production. Ann Rev Biochem 49: 395?420","journal-title":"Ann Rev Biochem"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0022-2275(20)37910-4","volume":"24","author":"JN Fain","year":"1983","unstructured":"Fain JN, Garcia-Sainz JA (1983) Adrenergic regulation of adipocyte metabolism. J Lipid Res 24: 945?966","journal-title":"J Lipid Res"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/0006-291X(82)92007-1","volume":"109","author":"Y Shechter","year":"1982","unstructured":"Shechter Y, Reitman P, Hizi A (1982) Evaluation of factors responsible for the inability of insulin to antagonize lipolysis due to high concentrations of catecholamine. Biochem Biophys Res Commun 109: 776?785","journal-title":"Biochem Biophys Res Commun"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"15553","DOI":"10.1016\/S0021-9258(19)37624-0","volume":"263","author":"P Engfeldt","year":"1988","unstructured":"Engfeldt P, Hellmer J, Wahrenberg H, Arner P (1988) Effects of insulin on adrenoceptor binding and the rate of catecholamine-induced lipolysis in isolated human fat cells. J Biol Chem 263: 15553?15560","journal-title":"J Biol Chem"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"14678","DOI":"10.1016\/S0021-9258(18)68090-1","volume":"263","author":"NA Abumrad","year":"1988","unstructured":"Abumrad NA, Harmon CM, Barnela US, Whitesell RR (1988) Insulin antagonism of catecholamine stimulation of fatty acid transport in the adipocytes. J Biol Chem 263: 14678?14683","journal-title":"J Biol Chem"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1016\/S0021-9258(17)35735-6","volume":"261","author":"NA Abumrad","year":"1986","unstructured":"Abumrad NA, Perry PR, Whitesell RR (1986) Insulin antagonizes epinephrine activation of the membrane transport of fatty acids. Potential site for hormonal suppression of lipid mobilization. J Biol Chem 261: 2999?3001","journal-title":"J Biol Chem"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"524","DOI":"10.2337\/diab.38.4.524","volume":"38","author":"H Wahrenberg","year":"1989","unstructured":"Wahrenberg H, Lonnqvist F, Engfeldt P, Arner P (1989) Abnormal action of catecholamine on lipolysis in adipocytes of type I diabetic patients treated with insulin. Diabetes 38: 524?533","journal-title":"Diabetes"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1172\/JCI111898","volume":"75","author":"MA Berk","year":"1985","unstructured":"Berk MA, Clutter WE, Skor D et al. (1985) Enhanced glycemic responsiveness to epinephrine in insulin dependent diabetes mellitus is the result of the inability to secrete insulin. Augmented insulin secretion normally limits the glycemic, but not the lipolytic or ketogenetic response to epinephrine in humans. J Clin Invest 75: 1842?1851","journal-title":"J Clin Invest"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/BF00506530","volume":"29","author":"I Lager","year":"1986","unstructured":"Lager I, Attval S, Eriksson BM, von Schenk H, Smith U (1986) Studies on the insulin antagonistic effect of catecholamines in normal man. Diabetologia 29: 409?416","journal-title":"Diabetologia"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2337\/diab.30.3.219","volume":"30","author":"JW Rowe","year":"1981","unstructured":"Rowe JW, Young JB, Minaker KL, Stevens AL, Pallotta J, Landsberg L (1981) Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes 30: 219?225","journal-title":"Diabetes"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0022-2275(20)38149-9","volume":"23","author":"PF Bougneres","year":"1982","unstructured":"Bougneres PF, Bier DM (1982) Stable isotope dilution method for measurement of palmitate content and labeled palmitate tracer enrichment in microliter plasma samples. J Lipid Res 23: 502?507","journal-title":"J Lipid Res"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1152\/ajpcell.1982.243.1.C7","volume":"243","author":"C Cobelli","year":"1982","unstructured":"Cobelli C, Nosadini R, Toffolo G et al. (1982) Model of the kinetics of ketone bodies in humans. Am J Physiol 243: R7-R17","journal-title":"Am J Physiol"},{"key":"CR17","first-page":"E131","volume":"249","author":"R Nosadini","year":"1985","unstructured":"Nosadini R, Avogaro A, Sacca' L et al. (1985) Ketone body metabolism in normal and diabetic human skeletal muscle. Am J Physiol 249: E131-E136","journal-title":"Am J Physiol"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1172\/JCI109840","volume":"66","author":"WE Clutter","year":"1980","unstructured":"Clutter WE, Bier DM, Shah SD, Cryer PE (1980) Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic action in man. J Clin Invest 66: 94?101","journal-title":"J Clin Invest"},{"key":"CR19","first-page":"1727","volume":"34","author":"B Lloyd","year":"1978","unstructured":"Lloyd B, Burrin J, Smythe P, Alberti KGMM (1978) Enzymic fluorometric continuous flow assays for blood glucose, lactate, pyruvate, alanine, glycerol, and 3-hydroxybutyrate. Clin Chem 34: 1727?1729","journal-title":"Clin Chem"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1172\/JCI110613","volume":"70","author":"PF Bougneres","year":"1982","unstructured":"Bougneres PF, Karl IE, Hillman LS, Bier DM (1982) Lipid transport in the human newborn: palmitate and glycerol turnover and the contribution of glycerol to hepatic glucose output. J Clin Invest 70: 262?270","journal-title":"J Clin Invest"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/0009-8981(66)90304-4","volume":"13","author":"L Hagenfeldt","year":"1966","unstructured":"Hagenfeldt L (1966) A gas chromatographic method for the determination of individual free fatty acids in plasma. Clin Chim Acta 13: 266?268","journal-title":"Clin Chim Acta"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/S0022-2275(20)38227-4","volume":"30","author":"A Avogaro","year":"1989","unstructured":"Avogaro A, Bier DM (1989) Contribution of 3-hydroxyisobutyrate to the measurement of 3-hydroxybutyrate in human plasma: comparison of enzymatic and gas chromatography-mass spectrometry assays in normal and diabetic subjects. J Lipid Res 30: 1811?1817","journal-title":"J Lipid Res"},{"key":"CR23","first-page":"E13","volume":"247","author":"P Hyemdahl","year":"1984","unstructured":"Hyemdahl P (1984) Catecholamine measurements by high performance liquid chromatography. Am J Physiol 247: E13-E20","journal-title":"Am J Physiol"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/2031141a0","volume":"203","author":"D Schalch","year":"1964","unstructured":"Schalch D, Parker M (1964) A sensitive double antibody radioimmunoassay for growth hormone in plasma. Nature 203: 1141?1142","journal-title":"Nature"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2337\/diab.26.1.22","volume":"26","author":"H Kuzuya","year":"1977","unstructured":"Kuzuya H, Blix PM, Horwitz DL, Steiner DF, Rubenstein AH (1977) Determination of free and total insulin and C-peptide in insulin treated diabetics. Diabetes 26: 22?29","journal-title":"Diabetes"},{"key":"CR26","first-page":"203","volume-title":"Glucagon. Handbook of experimental pharmacology, Vol. 66","author":"JW Ensick","year":"1983","unstructured":"Ensick JW (1983) Immunoassay for glucagon. In: Lefebvre P (ed) Glucagon. Handbook of experimental pharmacology, Vol. 66. Springer, New York, pp 203?221"},{"key":"CR27","first-page":"E103","volume":"258","author":"MD Jensen","year":"1990","unstructured":"Jensen MD, Heiling V, Miles JM (1990) Measurement of non steady state free fatty acid turnover. Am J Physiol 258: E103-E108","journal-title":"Am J Physiol"},{"key":"CR28","first-page":"E551","volume":"253","author":"C Cobelli","year":"1987","unstructured":"Cobelli C, Toffolo G, Bier DM, Nosadini R (1987) Models to interpret kinetic data in stable isotope tracer studies. Am J Physiol 253: E551-E564","journal-title":"Am J Physiol"},{"key":"CR29","doi-asserted-by":"crossref","unstructured":"Keller U, Sonnenberg GE, Stauffacher W (1981) Validation of a tracer technique to determine nonsteady state ketone body turnover rates in man. Am J Physiol E253?E262","DOI":"10.1152\/ajpendo.1981.240.3.E253"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"738","DOI":"10.2337\/diab.33.8.738","volume":"33","author":"M Weiss","year":"1984","unstructured":"Weiss M, Keller U, Stauffacher W (1984) Effects of epinephrine and somatostatin induced insulin deficiency on ketone body kinetics and lipolysis in man. Diabetes 33: 738?744","journal-title":"Diabetes"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/dmr.5610050604","volume":"5","author":"U Smith","year":"1989","unstructured":"Smith U, Lager I (1989) Insulin antagonistic effects of counter-regulatory hormones: clinical and mechanistic aspects. Diab Metab Rev 5: 511?525","journal-title":"Diab Metab Rev"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1210\/jcem-65-5-914","volume":"65","author":"M Beylot","year":"1987","unstructured":"Beylot M, Beaufrere B, Riou JP et al. (1987) Effect of epinephrine on the relationship between nonesterified fatty acid availability and ketone body production in postabsorptive man: evidence for a hepatic antiketogenetic effect of epinephrine. J Clin Endocrinol Metab 65: 914?921","journal-title":"J Clin Endocrinol Metab"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/dmr.5610050307","volume":"5","author":"R Nosadini","year":"1989","unstructured":"Nosadini R, Avogaro A, Doria A, Fioretto P, Trevisan R, Morocutti A (1989) Ketone body metabolism: a physiological and clinical overview. Diab Metab Rev 5: 299?319","journal-title":"Diab Metab Rev"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJM198403293101302","volume":"310","author":"M Press","year":"1984","unstructured":"Press M, Tamborlane WV, Sherwin RS (1984) Importance of raised growth hormone levels in mediating the metabolic derangements of diabetes. N Engl J Med: 310, 810?815","journal-title":"N Engl J Med"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1210\/jcem-54-3-665","volume":"54","author":"MH MacGillivray","year":"1982","unstructured":"MacGillivray MH, Li PK, Lee JT et al. (1982) Elevated plasma ?-hydroxybutyrate concentrations without ketonuria in healthy insulin-dependent diabetic patients. J Clin Endocrinol Metab 54: 665?668","journal-title":"J Clin Endocrinol Metab"},{"key":"CR36","first-page":"E542","volume":"259","author":"M Caruso","year":"1990","unstructured":"Caruso M, Divertie GD, Jensen MD, Miles JM (1990) Lack of effect of hyperglycemia on lipolysis in humans. Am J Physiol 259: E542-E547","journal-title":"Am J Physiol"},{"key":"CR37","first-page":"E694","volume":"254","author":"U Keller","year":"1988","unstructured":"Keller U, Gerber PPG, Stauffacher W (1988) Fatty acid independent inhibition of hepatic ketone body production by insulin in humans. Am J Physiol 254: E694-E699","journal-title":"Am J Physiol"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diab.38.12.1595","volume":"38","author":"MD Jensen","year":"1989","unstructured":"Jensen MD, Caruso M, Heiling V, Miles JM (1989) Insulin regulation of lipolysis in nondiabetic and IDDM subjects. Diabetes 38: 1595?1601","journal-title":"Diabetes"},{"key":"CR39","first-page":"E732","volume":"247","author":"U Keller","year":"1984","unstructured":"Keller U, Gerber PG, Stauffacher W (1984) Stimulatory effect of norepinephrine on ketogenesis in normal and insulin-deficient humans. Am J Physiol 247: E732-E739","journal-title":"Am J Physiol"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"738","DOI":"10.2337\/diab.33.8.738","volume":"33","author":"M Weiss","year":"1984","unstructured":"Weiss M, Keller U, Stauffacher W (1984) Effect of epinephrine and somatostatin-induced insulin deficiency on ketone body kinetics and lipolysis in man. Diabetes 33: 738?744","journal-title":"Diabetes"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0167-4889(83)90044-7","volume":"763","author":"MT Strosser","year":"1983","unstructured":"Strosser MT, Scala-Gvenot DD, Koch B, Mialhe P (1983) Inhibitory effect and mode of action of somatostatin on lipolysis in chicken adipocytes. Biochim Biophys Acta 763: 191?196","journal-title":"Biochim Biophys Acta"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0026-0495(90)90024-7","volume":"39","author":"KS Park","year":"1990","unstructured":"Park KS, Rhee BD, Lee KU, Lee HK, Koh CS, Min HK (1990) Hyperglycemia per se can reduce plasma free fatty acid and glycerol levels in acutely insulin deficient dog. Metabolism 39: 595?597","journal-title":"Metabolism"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00402544.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00402544\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00402544","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T19:11:25Z","timestamp":1624734685000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00402544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,2]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1992,2]]}},"alternative-id":["BF00402544"],"URL":"https:\/\/doi.org\/10.1007\/bf00402544","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,2]]}}}